Concepedia

Kurt Marhardt

KM

Statistics

Publications

7

Citations

361

H-Index

7

Active since

2014

Affiliations

MSD (Austria)(Current)

University Hospital of Lausanne

University College London

Amsterdam UMC Location Vrije Universiteit Amsterdam

University of Oslo

Kurt Marhardt is an author at MSD (Austria) specializing in interferon-based therapy, multiple sclerosis therapy, and multiple sclerosis.

Publications per year

2014–2021

7

Publications

7

Randomized trial of daily high-dose vitamin D <sub>3</sub> in patients with RRMS receiving subcutaneous interferon β-1a

Raymond Hupperts, Joost Smolders, Reinhold Vieth et al. · Neurology · 2019 · 132 citations · Full text

, , +17

High dose cholecalciferol (vitamin D3) oil as add-on therapy in subjects with relapsing-remitting multiple sclerosis (RRMS) receiving subcutaneous interferon β-1a (scIFNβ-1a) (S44.005)

Raymond Hupperts, Joost Smolders, Reinhard Vieth et al. · Neurology · 2017 · 64 citations

, , +13

Minocycline added to subcutaneous interferon β‐1a in multiple sclerosis: randomized <scp>RECYCLINE</scp> study

Per Soelberg Sørensen, Finn Sellebjerg, Jan Lycke et al. · European Journal of Neurology · 2016 · 43 citations

, , +17

Adherence to, and effectiveness of, subcutaneous interferon β-1a administered by RebiSmart® in patients with relapsing multiple sclerosis: results of the 1-year, observational SMART study

Antonios Bayas, Jean‐Christophe Ouallet, Boris Kallmann et al. · Expert Opinion on Drug Delivery · 2015 · 41 citations

, , +16

Subcutaneous interferon β-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study

Nicola De Stefano, Mark S. Freedman, Frederik Barkhof et al. · Journal of Neurology Neurosurgery & Psychiatry · 2016 · 40 citations · Full text

, , +16

1–5 of 7